PMC:7402624 / 40826-40978
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T375","span":{"begin":5,"end":8},"obj":"Body_part"},{"id":"T376","span":{"begin":19,"end":24},"obj":"Body_part"}],"attributes":[{"id":"A375","pred":"fma_id","subj":"T375","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A376","pred":"fma_id","subj":"T376","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"CD38+HLA-DR+ CD8 T cells (fig. S6E). In contrast, vasoactive medication, inhaled nitric oxide, and early steroid treatment were equally common in patien"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1432","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"1433","span":{"begin":13,"end":16},"obj":"Gene"},{"id":"1448","span":{"begin":81,"end":93},"obj":"Chemical"},{"id":"1449","span":{"begin":105,"end":112},"obj":"Chemical"}],"attributes":[{"id":"A1432","pred":"tao:has_database_id","subj":"1432","obj":"Gene:952"},{"id":"A1433","pred":"tao:has_database_id","subj":"1433","obj":"Gene:925"},{"id":"A1448","pred":"tao:has_database_id","subj":"1448","obj":"MESH:D009569"},{"id":"A1449","pred":"tao:has_database_id","subj":"1449","obj":"MESH:D013256"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CD38+HLA-DR+ CD8 T cells (fig. S6E). In contrast, vasoactive medication, inhaled nitric oxide, and early steroid treatment were equally common in patien"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T683","span":{"begin":0,"end":4},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T684","span":{"begin":13,"end":16},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T685","span":{"begin":17,"end":24},"obj":"http://purl.obolibrary.org/obo/CL_0000084"}],"text":"CD38+HLA-DR+ CD8 T cells (fig. S6E). In contrast, vasoactive medication, inhaled nitric oxide, and early steroid treatment were equally common in patien"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T286","span":{"begin":9,"end":11},"obj":"Chemical"},{"id":"T287","span":{"begin":81,"end":93},"obj":"Chemical"},{"id":"T288","span":{"begin":88,"end":93},"obj":"Chemical"},{"id":"T290","span":{"begin":105,"end":112},"obj":"Chemical"}],"attributes":[{"id":"A286","pred":"chebi_id","subj":"T286","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A287","pred":"chebi_id","subj":"T287","obj":"http://purl.obolibrary.org/obo/CHEBI_16480"},{"id":"A288","pred":"chebi_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/CHEBI_25741"},{"id":"A289","pred":"chebi_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/CHEBI_29356"},{"id":"A290","pred":"chebi_id","subj":"T290","obj":"http://purl.obolibrary.org/obo/CHEBI_35341"}],"text":"CD38+HLA-DR+ CD8 T cells (fig. S6E). In contrast, vasoactive medication, inhaled nitric oxide, and early steroid treatment were equally common in patien"}